Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Platform to Integrate Robotics, Synthetic Biology, A.I.

Microbes

Two companies are developing a new model for a cloud-based platform that makes possible automated collaborative research with artificial intelligence in synthetic biology. . . . → Read More: Platform to Integrate Robotics, Synthetic Biology, A.I.

Gene Therapy Biotech Acquired in $8.7 Billion Deal

A biotechnology enterprise developing gene therapies for rare inherited diseases and neurological disorders is being acquired by pharmaceutical company Novartis AG for $8.7 billion. . . . → Read More: Gene Therapy Biotech Acquired in $8.7 Billion Deal

New Company Acquires Off-the-Shelf T-Cell Cancer Therapies

A new enterprise is formed to develop treatments for cancer using donated T-cells from the immune system, rather than the patient’s own T-cells, engineered to attack cancer cells. . . . → Read More: New Company Acquires Off-the-Shelf T-Cell Cancer Therapies

Cough Suppressant Produced from Engineered Yeast Cells

A bioengineering group created a process for producing a cough suppressant in the lab, usually derived from opium poppies, but instead from genetically modified brewer’s yeast. . . . → Read More: Cough Suppressant Produced from Engineered Yeast Cells

Antibodies Licensed for Multi-Target Immunotherapies

MedImmune, the biologics subsidiary of drug maker AstraZeneca, is licensing antibodies from a biotechnology company for treatments that simultaneously address two or more cancer targets. . . . → Read More: Antibodies Licensed for Multi-Target Immunotherapies

RNA Treatment Tested for West Nile Virus

A therapy for West Nile Virus made with interfering RNA molecules is shown in lab mice to reduce viral loads, including in the brain where the disease can do serious damage. . . . → Read More: RNA Treatment Tested for West Nile Virus

Crowdsourced Project Building Whole Beta Cell Model

A new initiative is seeking participants from the worldwide research community to develop a multi-dimensional online model of the beta cell that produces insulin, found in the pancreas. . . . → Read More: Crowdsourced Project Building Whole Beta Cell Model

Crispr Enhanced to Find, Edit Tiny Mutations

A bioengineering lab at Harvard University designed a refinement for genome editing to identify and remove small genetic mutations that can lead to diseases or organisms resistant to current drugs. . . . → Read More: Crispr Enhanced to Find, Edit Tiny Mutations

High False-Positive Rate Found in Consumer Genetic Tests

Follow-up reviews of results from direct-to-consumer genetic tests show 40 percent of the actionable gene variations reported in the tests, including some indicating disease risk, were erroneous. . . . → Read More: High False-Positive Rate Found in Consumer Genetic Tests

Genome Editing Yields Quality Beer Without Hops

Academic scientists studying synthetic biology with help from professional brewers used genome editing to engineer yeast that produces beer with the taste of hops, but without adding hops. . . . → Read More: Genome Editing Yields Quality Beer Without Hops